CHEK1 and neoplasm: Such HR-deficient (HRD) tumours have mutations in key HR proteins including Ataxia-telangiectasia mutated (ATM), ataxia telangiectasia and Rad3-related protein (ATR), CHK1 and CHK2 (68).